Ahmed M Abu El-Asrar Selected Research

Chemokine CCL2 (Monocyte Chemoattractant Protein 1)

1/2017	Osteoprotegerin Is a New Regulator of Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy.
1/2013	High-mobility group box-1 induces decreased brain-derived neurotrophic factor-mediated neuroprotection in the diabetic retina.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ahmed M Abu El-Asrar Research Topics

Disease

53	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2023 - 08/2006
31	Epiretinal Membrane (Epiretinal Membranes) 10/2023 - 09/2006
30	Inflammation (Inflammations) 10/2023 - 04/2007
24	Uveitis 01/2023 - 09/2004
12	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 03/2024 - 10/2010
10	Hypoxia (Hypoxemia) 08/2023 - 06/2007
9	Retinal Detachment (Retinal Detachments) 10/2022 - 06/2005
7	Proliferative Vitreoretinopathy 08/2023 - 09/2006
6	Macular Edema 03/2021 - 06/2005
5	Fibrosis (Cirrhosis) 12/2014 - 03/2012
4	Tuberculosis (Tuberculoses) 06/2021 - 12/2008
4	Necrosis 01/2020 - 01/2010
4	Cataract (Cataracts) 01/2019 - 04/2010
3	Sarcoidosis (Schaumann Disease) 04/2020 - 01/2016
3	Glaucoma 02/2015 - 10/2009
2	Retinal Vasculitis 11/2023 - 10/2009
2	Endophthalmitis (Ophthalmia) 12/2022 - 05/2018
2	Retinitis 10/2022 - 08/2022
2	Retinal Perforations 10/2022 - 06/2014
2	Neoplasms (Cancer) 10/2021 - 01/2014
2	Ischemia 10/2020 - 06/2010
2	Vitreous Hemorrhage 10/2020 - 08/2006
2	Wounds and Injuries (Trauma) 05/2018 - 06/2014
2	Infections 01/2018 - 10/2010
2	Hemorrhage 08/2013 - 08/2006
2	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 11/2003 - 01/2003
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2022

Drug/Important Bio-Agent (IBA)

27	Retinaldehyde (Retinal)IBA 03/2024 - 06/2005
19	EnzymesIBA 09/2022 - 09/2004
19	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 06/2007
15	ImmunosorbentsIBA 01/2020 - 09/2004
13	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 04/2007
12	CytokinesIBA 08/2023 - 01/2012
11	Proteins (Proteins, Gene)FDA Link 02/2019 - 06/2007
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2013
9	ChemokinesIBA 01/2020 - 01/2003
8	HMGB1 Protein (HMG1)IBA 10/2019 - 01/2012
6	Oxygen (Dioxygen)IBA 03/2024 - 01/2014
6	cobaltous chloride (cobalt(II)chloride)IBA 08/2023 - 12/2016
6	Matrix Metalloproteinases (MMPs)IBA 09/2022 - 08/2006
6	Mycophenolic Acid (Cellcept)FDA LinkGeneric 03/2021 - 10/2010
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 01/2010
5	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2018 - 08/2006
4	Infliximab (Remicade)FDA Link 10/2022 - 06/2005
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 12/2021 - 09/2016
3	Fluorescein (Funduscein)FDA LinkGeneric 03/2021 - 10/2009
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 12/2016
3	Interleukin-6 (Interleukin 6)IBA 06/2018 - 01/2013
3	cadherin 5IBA 03/2015 - 01/2012
3	lysophosphatidic acidIBA 12/2014 - 03/2012
3	Chemokine ReceptorsIBA 06/2010 - 09/2006
2	LigandsIBA 10/2023 - 01/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 05/2018
2	Peptide Hydrolases (Proteases)FDA Link 09/2022 - 12/2016
2	Rituximab (Mabthera)FDA Link 04/2022 - 01/2021
2	Monoclonal AntibodiesIBA 04/2022 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2021 - 02/2015
2	Tissue Inhibitor of Metalloproteinase-3IBA 01/2021 - 02/2018
2	Streptozocin (Streptozotocin)FDA Link 01/2021 - 11/2014
2	Caspase 3 (Caspase-3)IBA 01/2021 - 02/2015
2	Interleukin-11 (Interleukin 11)IBA 05/2020 - 04/2020
2	Metalloproteases (Metalloproteinases)IBA 01/2020 - 02/2018
2	Interleukin-10 (Interleukin 10)IBA 08/2019 - 08/2012
2	InterleukinsIBA 08/2019 - 08/2012
2	Tuberculin (PPD)IBA 02/2019 - 12/2008
2	OsteoprotegerinIBA 01/2018 - 01/2017
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2017 - 01/2013
2	heparanaseIBA 01/2016 - 12/2015
2	Syndecan-1 (Syndecan 1)IBA 12/2015 - 01/2014
2	EndoglinIBA 03/2015 - 01/2012
2	Cadherins (E-Cadherin)IBA 03/2015 - 01/2012
2	Receptor for Advanced Glycation End ProductsIBA 02/2015 - 01/2013
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 02/2015 - 10/2009
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2015 - 01/2013
2	OsteopontinIBA 01/2014 - 01/2012
2	ThrombospondinsIBA 08/2013 - 05/2013
2	acylglycerol kinaseIBA 06/2013 - 03/2012
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2013 - 01/2013
2	InterferonsIBA 08/2012 - 11/2003
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2012 - 06/2010
2	pigment epithelium-derived factorIBA 01/2012 - 06/2007
2	Connective Tissue Growth FactorIBA 01/2012 - 02/2007
2	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 04/2011 - 04/2010
2	Triamcinolone (Aristocort)FDA Link 04/2011 - 04/2010
2	Chemotactic FactorsIBA 09/2004 - 11/2003
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2023
1	CD40 Ligand (CD40L)IBA 10/2023
1	Culture MediaIBA 08/2023
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 08/2023
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2023
1	BiglycanIBA 09/2022
1	Versicans (Versican)IBA 09/2022
1	Proteoglycans (Proteoglycan)IBA 09/2022
1	Ganciclovir (Cytovene)FDA LinkGeneric 08/2022
1	Acyclovir (Aciclovir)FDA LinkGeneric 08/2022

Therapy/Procedure

18	Therapeutics 08/2022 - 03/2005
6	Traction 06/2014 - 06/2005
4	Vitrectomy 01/2013 - 08/2006
3	Light Coagulation 11/2023 - 04/2010
3	Lasers (Laser) 11/2023 - 04/2010